Silverman Joshua — SEC Form 4 filings

SEC reporting owner CIK 1524858. 18 Form 4 filings on record with FilingPulse; latest filed 2026-08-14.

Transaction summary — filings shown

Covers all 18 filings on record, filed 2024-04-10 to 2026-08-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
PharmaCyte Biotech, Inc. (PMCB)CEO and President, Director23 legs · 100,000 sh · $80,4762
Fabric.AI, Inc. (FABC)Chief Executive Officer, Director37
TAO Synergies Inc. (TAOX)Executive Chairman, Director47
Q/C TECHNOLOGIES, INC. (QCLS)Executive Chairman, Director34
Petros Pharmaceuticals, Inc. (PTPI)Director33
FEMASYS INC (FEMY)Director32

Form 4 filings — Silverman Joshua

FiledFormIssuerReported transactionsSource
2026-08-144Fabric.AI, Inc. (FABC)Grant/award (A): 358,565 @ $0 · Tax withholding (F): 44,820 @ $3.70 · Tax withholding (F): 44,820 @ $3.69EDGAR
2026-06-054Petros Pharmaceuticals, Inc. (PTPI)Grant/award (A): 4,375,000 @ $0EDGAR
2026-05-194TAO Synergies Inc. (TAOX)Grant/award (A): 200,000 (derivative) @ $0EDGAR
2026-04-154Q/C TECHNOLOGIES, INC. (QCLS)Grant/award (A): 162,162 @ $0 · Grant/award (A): 100,000 (derivative) @ $0EDGAR
2026-03-184FEMASYS INC (FEMY)Holdings only — no transactions reportedEDGAR
2026-01-074PharmaCyte Biotech, Inc. (PMCB)Purchase (P): 30,000 @ $0.78 · Purchase (P): 30,000 @ $0.79 · Purchase (P): 40,000 @ $0.83EDGAR
2026-01-024Petros Pharmaceuticals, Inc. (PTPI)Grant/award (A): 4,375,000 @ $0EDGAR
2025-12-124PharmaCyte Biotech, Inc. (PMCB)Grant/award (A): 575,000 @ $0 · Tax withholding (F): 258,750 @ $1.02EDGAR
2025-11-144Q/C TECHNOLOGIES, INC. (QCLS)Grant/award (A): 91,356 @ $0EDGAR
2025-10-314StableX Technologies, Inc. (SBLX)Grant/award (A): 220,513 (derivative) @ $0EDGAR
2025-10-174TAO Synergies Inc. (TAOX)Grant/award (A): 100,000 @ $0 · Tax withholding (F): 40,000 @ $7.23 · Grant/award (A): 36,000 (derivative) @ $0EDGAR
2025-10-064Q/C TECHNOLOGIES, INC. (QCLS)Grant/award (A): 8,644 @ $0EDGAR
2025-07-024TAO Synergies Inc. (TAOX)Grant/award (A): 41,919 @ $0 · Tax withholding (F): 16,768 @ $7.85EDGAR
2025-06-274FEMASYS INC (FEMY)Grant/award (A): 17,600 (derivative) @ $0EDGAR
2025-02-214Petros Pharmaceuticals, Inc. (PTPI)Grant/award (A): 1,000,000 @ $0EDGAR
2024-12-024AYRO, Inc. (AYRO)Disposition to issuer (D): 6,166 @ $0 · Grant/award (A): 146,052 @ $0 · Option exercise (M): 97,368 (derivative) @ $0EDGAR
2024-07-154FEMASYS INC (FEMY)Grant/award (A): 17,600 (derivative) @ $0EDGAR
2024-04-104Synaptogenix, Inc. (SNPX)Grant/award (A): 800 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1524858 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →